Published in Gastroenterology on May 01, 2004
COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial) | NCT00132899
Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC) | NCT02516384
Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis | NCT02438410
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet (2007) 19.08
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Diversity, stability and resilience of the human gut microbiota. Nature (2012) 9.09
Inflammatory bowel disease. Annu Rev Immunol (2010) 7.10
The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev (2006) 6.80
The impact of the gut microbiota on human health: an integrative view. Cell (2012) 6.01
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet (2011) 5.58
Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med (2011) 5.30
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet (2006) 5.10
Canadian consensus on medically acceptable wait times for digestive health care. Can J Gastroenterol (2006) 4.34
Guidelines for the management of inflammatory bowel disease in adults. Gut (2004) 4.15
Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology (2011) 3.84
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology (2008) 3.79
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut (2006) 3.57
High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol (2011) 3.11
The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology (2014) 2.73
Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev (2013) 2.43
Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease. Am J Gastroenterol (2008) 2.41
A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol (2015) 2.35
A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nat Genet (2009) 2.26
Effects of family history on inflammatory bowel disease characteristics in Japanese patients. J Gastroenterol (2012) 2.17
Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci U S A (2011) 2.12
Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut (2006) 2.11
Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis. Aliment Pharmacol Ther (2015) 2.00
Estimating risks of common complex diseases across genetic and environmental factors: the example of Crohn disease. J Med Genet (2007) 1.97
Intestinal mucosal inflammation leads to systemic genotoxicity in mice. Cancer Res (2009) 1.90
Three-dimensional endomicroscopy of the human colon using optical coherence tomography. Opt Express (2009) 1.87
Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol (2007) 1.87
Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis (2010) 1.86
Dendritic cells in intestinal homeostasis and disease. J Clin Invest (2009) 1.83
Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease. J Pediatr Gastroenterol Nutr (2013) 1.82
Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study. PLoS One (2013) 1.78
Crohn's disease in Stockholm County during 1990-2001: an epidemiological update. World J Gastroenterol (2006) 1.73
Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med (2009) 1.71
Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem Biodivers (2010) 1.68
Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem (2009) 1.68
Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab (2008) 1.67
Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut (2005) 1.65
Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS One (2011) 1.58
Systematic association mapping identifies NELL1 as a novel IBD disease gene. PLoS One (2007) 1.57
Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev (2014) 1.57
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol (2013) 1.56
Diagnosis of Crohn's disease in India where tuberculosis is widely prevalent. World J Gastroenterol (2008) 1.56
Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. Gastroenterology (2010) 1.54
A murine model of ulcerative colitis: induced with sinusitis-derived superantigen and food allergen. BMC Gastroenterol (2005) 1.54
Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity (2011) 1.53
First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses. Am J Gastroenterol (2014) 1.53
Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol (2005) 1.51
CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammation. J Exp Med (2014) 1.49
Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2010) 1.48
Hospitalizations for inflammatory bowel disease among US military veterans 1975-2006. Dig Dis Sci (2009) 1.48
Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res (2016) 1.47
Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann N Y Acad Sci (2012) 1.47
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease. Sci Transl Med (2015) 1.46
Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther (2014) 1.45
Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease. Comp Med (2008) 1.44
Racial differences in disease activity and quality of life in patients with Crohn's disease. Dig Dis Sci (2014) 1.44
Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency. Dig Dis Sci (2015) 1.44
Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME J (2012) 1.43
Quantitative Assessment of Inflammation in a Porcine Acute Terminal Ileitis Model: US with a Molecularly Targeted Contrast Agent. Radiology (2015) 1.42
p120-catenin is essential for maintenance of barrier function and intestinal homeostasis in mice. J Clin Invest (2010) 1.41
Racial disparities in readmission, complications, and procedures in children with Crohn's disease. Inflamm Bowel Dis (2015) 1.40
Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan. J Gastroenterol (2012) 1.40
A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol (2013) 1.40
Exposing the weaknesses: a systematic review of azathioprine efficacy in ulcerative colitis. Dig Dis Sci (2008) 1.38
Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J Clin Invest (2013) 1.38
Mycobacterium avium subsp. paratuberculosis in lake catchments, in river water abstracted for domestic use, and in effluent from domestic sewage treatment works: diverse opportunities for environmental cycling and human exposure. Appl Environ Microbiol (2006) 1.37
Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study. BMC Musculoskelet Disord (2016) 1.36
Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production. J Immunol (2008) 1.35
Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine normal distal intestine. Infect Immun (2007) 1.35
The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol (2015) 1.34
Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study. Am J Gastroenterol (2016) 1.34
The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies. Int J Colorectal Dis (2008) 1.33
Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.33
New pathophysiological insights and modern treatment of IBD. J Gastroenterol (2010) 1.31
Anti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice. Clin Immunol (2011) 1.31
Think small: zebrafish as a model system of human pathology. J Biomed Biotechnol (2012) 1.30
Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A (2010) 1.29
Inflammasomes in intestinal inflammation and cancer. Gastroenterology (2011) 1.28
Improved risk prediction for Crohn's disease with a multi-locus approach. Hum Mol Genet (2011) 1.28
Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology (2008) 1.27
Inflammatory bowel disease: pathogenesis. World J Gastroenterol (2014) 1.26
The role of infection in the aetiology of inflammatory bowel disease. J Gastroenterol (2010) 1.26
Pulmonary-intestinal cross-talk in mucosal inflammatory disease. Mucosal Immunol (2011) 1.26
Immunopathogenesis of inflammatory bowel disease. Self Nonself (2011) 1.24
TNFSF15 is an ethnic-specific IBD gene. Inflamm Bowel Dis (2007) 1.24
1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages. J Immunol (2013) 1.24
The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology (2008) 1.23
Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis (2012) 1.22
Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individuals. J Proteome Res (2012) 1.21
Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing? World J Gastroenterol (2008) 1.21
Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut (2013) 1.21
Colitis and cancer: a tale of inflammatory cells and their cytokines. J Clin Invest (2008) 1.21
Prospective evaluation of MR enterography as the primary imaging modality for pediatric Crohn disease assessment. AJR Am J Roentgenol (2011) 1.20
The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol (2010) 1.19
Small-bowel MRI in children and young adults with Crohn disease: retrospective head-to-head comparison of contrast-enhanced and diffusion-weighted MRI. Pediatr Radiol (2012) 1.18
Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot study. Dig Dis Sci (2007) 1.16